Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > cash into 2025?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(28)
•••
Comment by tigerproon Jan 11, 2024 9:52pm
71 Views
Post# 35822870

RE:cash into 2025?

RE:cash into 2025?There is no way they can do capital increase in the future.  Nobody believes them anymore. The management team has lost their credit.     After merge,  bankruptcy after 2025 is the only possible result for the new company.  

Without merge, CZO's CEO will lose his job after this year's annual shareholder meeting. He knows this very well. 

After merge, he can keep his job for 2 years longer and earn 1M $ more.    (he will go retired after the new company bankrupt in 2026)


This is the main reason he choose the merge.      We have to vote No.   If the merge is succussful, the new company's stock price will be 0 after 2025. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities